SAN DIEGO–(BUSINESS WIRE)–Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of the Dexcom G6 Mobile App in Spanish, available immediately for users with a compatible iOS (v1.10.1) or Android (v1.10.0) smart device.
Diabetes disproportionately affects Latinos, and as of 2022, an estimated 11.8% of US Latino adults have been diagnosed with diabetes.1 Additionally, the CDC estimates that US Latinos have a greater than 50% chance of developing type 2 diabetes, with a higher risk of complications.2
“With countless studies pointing to language barriers in healthcare that create misunderstandings between patients and healthcare providers3 and declining quality of care and patient safety, it is important to provide access to diabetes information in the patient’s preferred language to improve health outcomes,” said Ana-Mari Calleja Carr, District Business Manager at Dexcom, representing the South Florida region. “The launch of the Dexcom G6 app in Spanish is a positive step towards improving health equity for people with diabetes who are primarily Spanish speakers.”
To access the Spanish Dexcom G6 app, users must install the latest version of the app and set up their compatible iOS (v1.10.1) or Android (v1.10.0) smartphone* Language to Spanish (any dialect/any region). The app will automatically appear in Spanish as long as the phone language is set to Spanish.
“Being able to offer this powerful CGM technology to my Spanish-speaking patients in their preferred language can help them better understand their diabetes and manage their health more proactively,” said Dr. Rocio Harbison, MD, FACE, a treating endocrinologist a large Spanish-speaking population. “CGM technology is one of the most powerful diabetes management tools available, and this new development from Dexcom will help improve access for Spanish speakers who often need to manage their health with limited Spanish language tools.”
Dexcom G6 uses a small, wearable sensor and transmitter to continuously measure and wirelessly send glucose levels to a compatible smart device* or receiver that provides patients with real-time glucose data without having to prick their fingers.† The system also offers customizable alerts and alarms to help prevent potentially dangerous low and high blood glucose events.
“It’s great to see that Dexcom has invested in developing a Spanish-language app for patients,” said Siena Ruelas, a professional soccer player and Dexcom warrior who suffers from type 1 diabetes. “This offering will help remove a significant barrier to accessing critical glucose information and improve the ability to make important health decisions.”
The Dexcom Follow app is not immediately available in Spanish, but functionality will be added in a future product update. For more information in Spanish about the Dexcom G6, visit Dexcom.com/ayuda.
About DexCom, Inc.
DexCom, Inc. enables people to take control of diabetes through innovative real-time continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, with offices throughout Europe and select parts of Asia/Oceania, Dexcom has grown into a leading provider of diabetes care technologies. By listening to the needs of users, caregivers and providers, Dexcom works to simplify and improve diabetes management around the world. For more information on Dexcom CGM, visit www.dexcom.com.
*For a list of compatible devices, see www.dexcom.com/compatibility.
†If your glucose alerts and readings from the G6 do not match symptoms or expectations, or you exceed the recommended maximum dose of 1000 mg acetaminophen every 6 hours, use a blood glucose meter to help make diabetes management decisions.
© 2022 Dexcom, Inc. Dexcom, Dexcom G6 and Dexcom Follow are registered trademarks of DexCom, Inc. in the US and may be registered in other countries. All rights reserved.